Due to increased R&D costs, AbbVie lowers its full-year profit outlook.
AbbVie Inc (ABBV.N) cut full-year profit forecast due to unfavorable impact from R&D and…
Humira, manufactured by AbbVie, is now available from Fresenius at a 5% discount.
The generic drug unit of Germany's Fresenius said on Monday the price…
Genmab-AbbVie’s blood cancer treatment has received US FDA approval.
The U.S. Food and Drug Administration has approved AbbVie Inc and Danish…
AbbVie intends to withdraw several blood cancer therapies from US speedy approval.
AbbVie Inc intends to voluntarily withdraw in the U.S. the accelerated approvals…